June 13th, 2022

Scilligence partners with to co-develop ELN-based data integration

November 17, 2020

Scilligence Partners with CAS to Optimize R&D Informatics Workflows with Scientist-Curated Data


Scilligence Gives Back During the COVID-19 Pandemic

January 6, 2020

Scilligence and CAS Collaborate to Integrate SciFinder with ELN

December 5, 2019

Scilligence and Certara Partner to Improve Client’s Data Analysis and Visualization

Zifo RnD Solutions and Scilligence Announce Strategic Partnership

HitGen has Licensed Scilligence’s ELN and RegMol

CAMBRIDGE, Mass. and BOSTONJune 11, 2019 

Scilligence and TetraScience Announce Integration Plan to Automate Research Data

Princeton University Licenses Scilligence’s Platform

The Global Health Drug Discovery Institute (GHDDI) Licenses Scilligence ELN

New York, April 12, 2019

Scilligence and Elsevier Collaborate to Enhance Lab Efficiency

Jan. 23, 2019

Scilligence Joins Accenture’s Life Sciences Research Platform Ecosystem to Help Drive Innovation in Drug Discovery and Scientific Research

Boston, November 14, 2018

Scilligence Joins Merck and Accenture During the AWS re:Invent Conference

Boston, March 21, 2018

Announcing Support for HELM 1.1 (Hierarchical Editing Language for Macromolecules) in the Open Source Web Editor

Wednesday, February 28, 2018

Scilligence EU Expansion and Beyond

Boston, June 9, 2017

Scilligence Receives ISO 27001:2013 and 9001:2015 Certifications

Boston, February 16, 2017 

Biomimetic Drugs at Peking University has licensed Scilligence’s RegMol and Inventory systems

Boston, February 14, 2017

The Institute of Medicinal Plant Development has licensed Scilligence’s TouchMol4Office

Boston, February 7, 2017

The Pistoia Alliance and Scilligence Announce HELM Web Editor

January 12, 2016

Shanghai Hengrui Pharmaceutical Co., Ltd. has licensed Scilligence ELN

December 22, 2016

Shanghai Syn-The-All Pharmaceutical Co. Ltd. (STA) has licensed Scilligence ELN

August 11, 2016

Scilligence Launches New Brand Identity